Track the Septerna, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 13 August 2026 (Levée d'options). Among the most active insiders: Bhatt Elizabeth. The full history is openly available.
36
Insider Decl.
n/a
Thresholds
€4m
7 ops.
Buy Volume
€1m
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Septerna, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$45.00.
35Σ signal
Buys €4m€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,501 shares@ US$18.0586100.0% of flowCommon StockSEC:0001193125-25-280756:0
25 of 36 declarations
Acerca de Septerna, Inc.
Septerna, Inc. es una empresa que cotiza en el mercado XNAS. Se especializa en el desarrollo de soluciones innovadoras en el sector de la biotecnología.